Evidence map›Paper›PMID 20620669›Full record

ReviewSeminars in nephrology2010

Macrophages and immunologic inflammation of the kidney.

Jeremy S Duffield

Open access · greenAbstract readReview
In one paragraph

Review in Seminars in nephrology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 136 papers.

0numbers the graph read from it
0cells of the map it votes in
136citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

136 citing papers in PubMed, 230 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. EGF-Receptor-Dependent TLR7 Signaling in Macrophages Promotes Glomerular Injury in Crescentic Glomerulonephritis.Laboratory investigation; a journal of technical methods and pathology · 2023
    Article
  20. Article

76 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Jeremy S DuffieldLaboratory of Inflammation Research, Renal Division, Department of Medicine, Brigham & Women's Hospital, Boston, MA, USA. jduffield@rics.bwh.harvard.edu
Harvard Stem Cell Institute · US

Funding

The role of Macrophage Delivered WNT Signaling in kidney injury and repairR01DK084077 · NIDDK · UNIVERSITY OF WASHINGTON · PI SHANKLAND, STUART JAMES · 2009 to 2013
$1.8M
Kidney pericytes in vascular regeneration after injuryRC1DK087389 · NIDDK · UNIVERSITY OF WASHINGTON · PI DUFFIELD, JEREMY S · 2009 to 2010
$989k
DEFINING INJURIOUS & REPARATIVE MACROPHAGES IN KIDNEY INJURY AND REPAIRK08DK073299 · NIDDK · UNIVERSITY OF WASHINGTON · PI DUFFIELD, JEREMY S · 2006 to 2010
$677k
NIDDK NIH HHS DK73299NIDDK NIH HHS DK84077NIDDK NIH HHS DK87389NIDDK NIH HHS K08 DK073299NIDDK NIH HHS R01 DK084077NIDDK NIH HHS RC1 DK087389
6 · The paper itself

Abstract

Monocyte-derived tissue effector cells, macrophages, are present in large numbers in all forms of kidney disease with inflammation. Their roles in inflammation and the molecular effectors of macrophage function have been difficult to decipher. With the advent of modern genetic tools and mouse models of human disease, great insight into monocyte/macrophage biology has been forthcoming. This review places macrophage study in its historical context, defines immunologic diseases of the kidney, broadens its definition to encompass current thinking of the immune response to kidney injury, highlights key advances of the study of monocyte/macrophages in kidney diseases, and identifies new therapeutic pathways and targets that hinge around macrophage function. This article advances the case that targeting macrophage activation and phenotype is leading to new therapies in the treatment of many acute and chronic kidney diseases.

Indexed as

Acute DiseaseAnimalsAutoimmunityChronic DiseaseFibrosisHumansImmunity, InnateKidneyMacrophage ActivationMacrophagesMiceMonocytesNephritisRats

Identifiers

PMID20620669
PMCPMC2922007
OpenAlexW1994455716

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.